United States · FDA National Drug Code directory
Sumatriptan and Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-928_b0441826-19e2-4113-89b7-727a2b882a09
- Product NDC
- 65862-928
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sumatriptan and Naproxen Sodium
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180215
- Source listing expiry
- 20261231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 85 mg/1
- NAPROXEN SODIUM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 TABLET, FILM COATED in 1 BOTTLE (65862-928-36) · 65862-928-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →